Clients

Q Biomed Inc.

Company Snapshot: Q Biomed Inc.

QBIO
Last Change Volume High Low

Company Overview

Q BioMed Inc. is a biomedical acceleration and development company. We are dedicated to acquiring and providing strategic resources and expansion capital to innovative healthcare companies that strive to provide much needed healthcare and related products to patients in need.

By partnering with exceptional entrepreneurs we aim to help to create market-leading products and companies in the biomedical and healthcare sector. As entrepreneurs and investors with operational and technical expertise we embrace a collaborative approach to capital formation and business development.

Client News

  1. Jul 11 2019 Q BioMed Announces Updates on Commercialization of Non-Opioid Metastatic Cancer Pain Drug
  2. Jun 28 2019 Q BioMed Files for Orphan Drug Designation with U.S. FDA for Autism Spectrum Disorder Subtype
  3. Jun 24 2019 Q BioMed Responds to OTC Markets Request for Clarity on Promotional Activity
  4. Jun 24 2019 Q BioMed Responds to OTC Markets Request for Clarity on Promotional Activity
  5. Jun 4 2019 Q BioMed Advances QBM-001 for the Treatment of Autism Spectrum Disorder Subtype